Analyst Price Targets — VVOS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 17, 2026 1:45 pm | — | H.C. Wainwright | $2.50 | $1.01 | TheFly | Vivos Therapeutics price target lowered to $2.50 from $7 at H.C. Wainwright |
| April 17, 2026 12:26 pm | — | Industrial Alliance Securities | $1.75 | $1.00 | TheFly | Vivos Therapeutics price target lowered to $1.75 from $2.50 at Alliance Global |
| May 20, 2025 11:03 am | Scott Henry | Industrial Alliance Securities | $2.25 | $2.15 | TheFly | Vivos Therapeutics downgraded to Neutral from Buy at Alliance Global Partners |
Latest News for VVOS
LITTLETON, Colo., June 30, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing‑related sleep disorders such as obstructive sleep apnea (OSA), insomnia, and associated chronic health conditions, today announced compelling clinical data showing that treatment with its FDA‑cleared…
Vivos and Streeterville Extend Timeframe of Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity
LITTLETON, Colo., June 11, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated chronic health conditions, including mild-to-severe obstructive sleep apnea (“OSA”), today announced that it intends to file a registration statement with the U.S.…
Vivos Announces Collaboration Agreement with Florida Cardiology Group to Extend Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients
LITTLETON, Colo., June 08, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated chronic health conditions, including obstructive sleep apnea (“OSA”), today announced that members of its executive management team will participate in The Small…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for VVOS.
U.S. House Trading
No House trades found for VVOS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.